Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/SANOFI-4698/actualite/Sanofi-Dupixent-dupilumab-a-montre-des-resultats-de-phase-III-positifs-dans-le-traitement-de-29018332/?utm_source=whatsapp&utm_medium=social&utm_campaign=share